Schellens J. | Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
スポンサーリンク
概要
- SCHELLENS J. H. M.の詳細を見る
- 同名の論文著者
- Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical Anの論文著者
関連著者
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Beijnen J
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Beijnen Jos
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Beijnen Jos
University Of Utrecht Department Of Pharmaceutical Analysis
-
Sparidans R
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen Jos
Utrecht University Faculty Of Pharmacy Department Of Biomedical Analysis Division Of Drug Toxicology
-
Sparidans Rolf
Utrecht University Faculty Of Pharmacy Department Of Biomedical Analysis Division Of Drug Toxicology
-
SCHELLENS Jan
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
Beijnen J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Schinkel Afred
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
Van Den
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Rosing H
Netherlands Cancer Inst. Amsterdam Nld
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital/netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy Slotervaart Hospital
-
BEIJNEN Jos
University of Utrecht, Department of Pharmaceutical Analysis
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
SPARIDANS Rolf
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
SCHELLENS Jan
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
SPARIDANS Rolf
Utrecht University, Faculty of Pharmacy, Department of Pharmaceutical Analysis
-
BEIJNEN Jos
Utrecht University, Faculty of Pharmacy, Department of Pharmaceutical Analysis
-
Rosing Hilde
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
LAGAS Jurjen
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
Lagas Jurjen
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
Van Den
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
ROSING Hilde
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
Beijnen Jos
Department Of Clinical Chemistry The Netherlands Cancer Institute
-
TEUNISSEN S.
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
SCHINKEL A.
Department of Molecular Biology, The Netherlands Cancer Institute
-
Schinkel A.
Department Of Molecular Biology The Netherlands Cancer Institute
-
Teunissen S.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
BEIJNEN Jos
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
BEIJNEN J.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
Huitema A.
Slotervaart Hospital Department Of Pharmacy & Pharmacology
-
Huitema A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital
-
IUSUF Dilek
The Netherlands Cancer Institute, Division of Molecular Biology
-
SCHINKEL Alfred
The Netherlands Cancer Institute, Division of Molecular Biology
-
Iusuf Dilek
The Netherlands Cancer Institute Division Of Molecular Biology
-
Fiebig Heinz-herbert
Ontcotest Gmbh
-
Bosch T.
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
VAINCHTEIN Liia
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
MAIER Armin
Ontcotest GmbH
-
SCHELLENS Jan
Division of Drug Toxicology, Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences,
-
ROSING H.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
TEN BOKKEL
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute
-
Rosing Hilde
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Ten Bokkel
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Van Tellingen
Department Of Clinical Chemistry The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Van Tellingen
Department Of Clinical Chemistry Antoni Van Leeuwenhoek Hospital Netherlands Cancer Institute
-
Schellens Jan
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
BULT Auke
Department of Biomedical Analysis, Faculty of Pharmaceutical Sciences, Utrecht University
-
Bult Auke
Free University Amsterdam Department Of Analytical Chemistry And Applied Spectroscopy
-
Fraier Daniela
Pharmacia And Upjohn Drug Metabolism Research Pharmacokinetics And Metabolism Department
-
SPARIDANS R.
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
HUITEMA A.
Slotervaart Hospital, Department of Pharmacy & Pharmacology
-
SCHELLENS J.
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
Sparidans R.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
SCHOEMAKER Nadja
Department of Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlands Cancer Institute
-
FRIGERIO Enrico
Pharmacia and Upjohn, Drug Metabolism Research, Pharmacokinetics and Metabolism Department
-
JANSEN Sindy
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
Vainchtein Liia
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
SCHINKEL Afred
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
JORGER M.
The Netherlands Cancer Institute, Department of Medical Oncology
-
CROMMENTUYN Kristel
Slotervaart Hospital, Department of Pharmacy and Pharmacology
-
KEMPER E.
Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis
-
JANSEN B.
Department of Clinical Chemistry, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis
-
BROUWER K.
Glaxo Wellcome, Five Moore Drive
-
Jansen Sindy
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Jorger M.
The Netherlands Cancer Institute Department Of Medical Oncology
-
BULT A.
Department of Pharmaceutical Analysis and Toxicology, Faculty of Pharmacy, University of Utrecht
-
VAN ZOMEREN
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
DOYLE E.
Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals
-
Van Zomeren
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Frigerio Enrico
Pharmacia And Upjohn Drug Metabolism Research Pharmacokinetics And Metabolism Department
-
Doyle E.
Department Of Drug Analysis Smithkline Beecham Pharmaceuticals
-
Kemper E.
Department Of Clinical Chemistry The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Tibben Matthijs
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Schellens Jan
Department Of Clinical Pharmacology The Netherlands Cancer Institute
-
Damen Carola
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Hillebrand M.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
SCHINKEL A.
Division of Molecular Biology, The Netherlands Cancer Institute
-
VLAMING M.
Department of Molecular Biology, The Netherlands Cancer Institute
-
VAN VELSEN
University Medical Centre Utrecht, Department of Dermatology and Allergology
-
DE ROOS
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
BRUIJNZEEL-KOOMEN Carla
University Medical Centre Utrecht, Department of Dermatology and Allergology
-
LANKHEET A.
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
LANGENBERG M.
Department of Medical Oncology, University Medical Center Utrecht
-
VOEST E.
Department of Medical Oncology, University Medical Center Utrecht
-
SCHELLENS J.
Beta Faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Utrecht Univer
-
KOORNSTRA R.
Departments of Molecular Biology and Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlan
-
LINN S.
Departments of Molecular Biology and Medical Oncology, Antoni van Leeuwenhoek Hospital/The Netherlan
-
VLAMING Maria
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
VAN MAANEN
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
LAGAS Jurjen
Department of Experimental Therapy, The Netherlands Cancer Institute
-
SCHINKEL Alfred
Department of Experimental Therapy, The Netherlands Cancer Institute
-
SCHELLENS Jan
Beta Faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Utrecht Univer
-
Crommentuyn Kristel
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Brouwer K.
Glaxo Wellcome Five Moore Drive
-
De Roos
Universiteit Utrecht Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical
-
Linn S.
Departments Of Molecular Biology And Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherland
-
Voest E.
Department Of Medical Oncology University Medical Center Utrecht
-
Van Velsen
University Medical Centre Utrecht Department Of Dermatology And Allergology
-
Vlaming M.
Department Of Molecular Biology The Netherlands Cancer Institute
-
Vlaming Maria
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
Van Maanen
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Lankheet A.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Koornstra R.
Departments Of Molecular Biology And Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherland
-
Langenberg M.
Department Of Medical Oncology University Medical Center Utrecht
-
GOEY Andrew
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
MEIJERMAN Irma
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
Meijerman Irma
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schoemaker Nadja
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Bruijnzeel-koomen Carla
University Medical Centre Utrecht Department Of Dermatology And Allergology
-
Jansen B.
Department Of Clinical Chemistry The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Goey Andrew
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
著作論文
- Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometry
- Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry
- Enzymatic digestion as a tool for the LC-MS/MS quantification of large peptides in biological matrices : Measurement of chymotryptic fragments from the HIV-1 fusion inhibitor enfuvirtide and its metabolite M-20 in human plasma
- High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma
- Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver brain and small intestinal contents and in OptiMEM cell culture medium
- Liquid chromatography-tandem mass spectrometric assay for the analysis of uracil, 5,6-dihydrouracil and β-ureidopropionic acid in urine for the measurement of the activities of the pyrimidine catabolic enzymes
- Liquid chromatographic assay for the antiviral nucleotide analogue tenofovir in plasma using derivatization with chloroacetaldehyde
- Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- Review on the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in biological matrices, foodstuff and beverages
- Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates
- Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
- Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis
- Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
- Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
- Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry
- A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry
- A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma